 potential disease modifying treatment. I believe there has already been a phase one and phase two trial looking to see if these drugs can potentially prevent Alzheimer's disease. They've already shown that they can reduce the risk of cardiovascular events. And insofar as, I mean, these drugs have been used for decades at this point as drugs to treat type two diabetes. And so only recently has it been approved to treat obesity.